BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36412487)

  • 1. Which motor-cognitive abilities underlie the digital Trail-Making Test? Decomposing various test scores to detect cognitive impairment in Parkinson's disease-Pilot study.
    Park SY; Schott N
    Appl Neuropsychol Adult; 2022 Nov; ():1-15. PubMed ID: 36412487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trail-making-test: Comparison between paper-and-pencil and computerized versions in young and healthy older adults.
    Park SY; Schott N
    Appl Neuropsychol Adult; 2022; 29(5):1208-1220. PubMed ID: 33397159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent analysis of a digital Trail Making Test.
    Fellows RP; Dahmen J; Cook D; Schmitter-Edgecombe M
    Clin Neuropsychol; 2017 Jan; 31(1):154-167. PubMed ID: 27690752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysexecutive difficulty and subtle everyday functional disabilities: the digital Trail Making Test.
    Libon DJ; Swenson R; Tobyne S; Jannati A; Schulman D; Price CC; Lamar M; Pascual-Leone A
    Front Neurol; 2024; 15():1354647. PubMed ID: 38633534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital trail making test-black and white: Normal vs MCI.
    Simfukwe C; Youn YC; Kim SY; An SS
    Appl Neuropsychol Adult; 2022; 29(6):1296-1303. PubMed ID: 33529537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease.
    Ryu J; Vero J; Dobkin RD; Torres EB
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31403620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Development of a Novel Proprioceptive Trail-Making Test: Comparing Healthy Dancers and Non-Dancers.
    Card MR; Ryals AJ
    Percept Mot Skills; 2024 Jun; 131(3):660-686. PubMed ID: 38537176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturalistic smartphone keyboard typing reflects processing speed and executive function.
    Ross MK; Demos AP; Zulueta J; Piscitello A; Langenecker SA; McInnis M; Ajilore O; Nelson PC; Ryan KA; Leow A
    Brain Behav; 2021 Nov; 11(11):e2363. PubMed ID: 34612605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Motor and Cognitive Performance in People with Parkinson's Disease Using Instrumented Trail-Making Test.
    Mishra RK; Park C; Zhou H; Najafi B; Thrasher TA
    Gerontology; 2022; 68(2):234-240. PubMed ID: 33940574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    Wojtala J; Heber IA; Neuser P; Heller J; Kalbe E; Rehberg SP; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Dodel R; Schulz JB; Reetz K
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):171-179. PubMed ID: 30297519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional associations between cognition and mobility in Parkinson's disease.
    Sousa NMF; Macedo RC; Brucki SMD
    Dement Neuropsychol; 2021; 15(1):105-111. PubMed ID: 33907603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved executive function in patients with systemic lupus erythematosus following interactive digital training.
    Kozora E; Zell JL; Baraghoshi D; Smith RM; Strand M
    Lupus; 2022 Jul; 31(8):910-920. PubMed ID: 35584197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor-Independent Cognitive Testing in Motor Degenerative Diseases.
    Schmitz-Peiffer H; Aust E; Linse K; Rueger W; Joos M; Löhle M; Storch A; Hermann A
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emphasizing speed or accuracy in an eye-tracking version of the Trail-Making-Test: Towards experimental diagnostics for decomposing executive functions.
    Recker L; Foerster RM; Schneider WX; Poth CH
    PLoS One; 2022; 17(9):e0274579. PubMed ID: 36094948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson's disease.
    Tong SY; Wang RW; Li Q; Liu Y; Yao XY; Geng DQ; Gao DS; Ren C
    Front Neurosci; 2023; 17():1136499. PubMed ID: 36908789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a digital, tablet-based version of the Trail Making Test in the ∆elta platform.
    Baykara E; Kuhn C; Linz N; Tröger J; Karbach J
    Eur J Neurosci; 2022 Jan; 55(2):461-467. PubMed ID: 34811827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving Trail Making Test part B: a variant of the TMT-B.
    Lee S; Lee JA; Choi H
    J Phys Ther Sci; 2016 Jan; 28(1):148-53. PubMed ID: 26957747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.